Search - tctmd.com

Displaying 261 - 280 of 2322

Sort: Relevancy | Date

RNA-Interference Agent Zilebesiran Looks Promising for BP-Lowering KARDIA-1

News Conference News AHA 2023

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

Caitlin E. Cox

November 11, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

L.A. McKeown

November 03, 2023

News Conference News TCT 2023

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

Todd Neale

October 31, 2023

Presentation TCT 2023

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

Presenter: Ajay Kirtane

October 26, 2023

Presentation TCT 2023

Debate – Most PCI Operators Should Not Be Performing Renal Denervation (Con)

Presenter: Dmitriy Feldman

October 25, 2023

Presentation TCT 2023

Debate – Most PCI Operators Should Be Able to Perform Renal Denervation (Pro)

Presenter: Andrew Sharp

October 25, 2023

Presentation TCT 2023

How to Perform rRDN (Medtronic) – Step by Step

Presenter: Tai Kobayashi

October 25, 2023

Presentation TCT 2023

How to Perform uRDN (Recor) – Step by Step

Presenter: Chandan Devireddy

October 25, 2023

Presentation TCT 2023

Clinical and Imaging Workup Prior to RDN

Presenter: Debbie Cohen

October 25, 2023

Presentation TCT 2023

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TCT 53: Every Third Patient with Advanced Renal Failure Dies Within One Year Following Non ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention

Presenter: Rafal Januszek

October 25, 2023

Presentation TCT 2023

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Presenter: Ajay Kirtane

October 25, 2023

Presentation TCT 2023

Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant?

Presenter: Lucas Lauder

October 25, 2023

Presentation TCT 2023

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Presenter: Michael Bloch

October 25, 2023

Presentation TCT 2023

TCT 697: Impact of Coronary Atherosclerotic Burden on the Long-Term Prognosis of Patients With Chronic Kidney Disease Undergoing Renal Replacement Therapy

Presenter: Roger Godinho

October 25, 2023

Advertisement

RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

FDA Approves Paradise Renal Denervation System: What Comes Next?

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

Debate – Most PCI Operators Should Not Be Performing Renal Denervation (Con)

Debate – Most PCI Operators Should Be Able to Perform Renal Denervation (Pro)

How to Perform rRDN (Medtronic) – Step by Step

How to Perform uRDN (Recor) – Step by Step

Clinical and Imaging Workup Prior to RDN

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

TCT 53: Every Third Patient with Advanced Renal Failure Dies Within One Year Following Non ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Preclinical Science In Renal Denervation – What Is New, What Is Clinically Relevant?

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

TCT 697: Impact of Coronary Atherosclerotic Burden on the Long-Term Prognosis of Patients With Chronic Kidney Disease Undergoing Renal Replacement Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content